Exscientia Announces Second Molecule Created Using AI
Second clinical molecule from Exscientia collaboration with Sumitomo Dainippon Pharma to begin Phase 1 trials in United States. Clinical study of DSP-0038, a dual targeted...
Tag : clinical testing
Iktos and Facio Therapies Collab to Use AI for FSHD Drug Design
Iktos, a company specialized in Artificial Intelligence for new drug design, and Facio Therapies, a drug discovery and development company focused on developing treatments for...
Pfizer & BioNTech Authorized for COVID Vaccine Emergency Use in Adolescents
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years Data also submitted to...
Healthtech Heartbeat Health Raises $20M to Expand Virtual Heart Care
Heartbeat Health, a healthcare company working to deliver the most effective, efficient, and engaging heart care, announced today that it has raised $20 million in...
Leading mRNA Vaccine Company Moderna Announces Expansion of MTC
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an expansion of the Moderna Technology Center (MTC) in Norwood,...
Altru Health System Powers Clinical Trial Offering with Deep Lens
VIPER™ will identify and match eligible patients to oncology clinical trials faster and with improved efficiencies across Altru Health System’s network Deep Lens and Altru...
Angie Stevens Joins Leading Digital Health Solutions Provider
Iron Bow Healthcare Solutions, a digital health solutions and global managed services provider to healthcare, commercial and government markets, today announced Angie Stevens will be...
Clinical Communication Co. Vocera to Acquire PatientSafe Solutions
Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today announced it is acquiring PatientSafe Solutions based in San Diego, CA. PatientSafe...
ZYUS Launches HOPE Phase 1 First in Human Clinical Trials
Phase 1a/1b clinical trials beginning April 2021 will assess the safety and tolerability of ZYUS’ lead drug product candidate in healthy adult participants ZYUS Life...
Oregon Oncology Specialists Integrates AI Clinical Trial Screening
Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform, VIPER™, into their...